1. Home
  2. ADMA vs LOAR Comparison

ADMA vs LOAR Comparison

Compare ADMA & LOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • LOAR
  • Stock Information
  • Founded
  • ADMA 2004
  • LOAR 2012
  • Country
  • ADMA United States
  • LOAR United States
  • Employees
  • ADMA N/A
  • LOAR N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • LOAR
  • Sector
  • ADMA Health Care
  • LOAR
  • Exchange
  • ADMA Nasdaq
  • LOAR NYSE
  • Market Cap
  • ADMA 5.8B
  • LOAR 6.3B
  • IPO Year
  • ADMA N/A
  • LOAR 2024
  • Fundamental
  • Price
  • ADMA $19.98
  • LOAR $95.86
  • Analyst Decision
  • ADMA Strong Buy
  • LOAR Strong Buy
  • Analyst Count
  • ADMA 4
  • LOAR 4
  • Target Price
  • ADMA $24.25
  • LOAR $84.00
  • AVG Volume (30 Days)
  • ADMA 4.5M
  • LOAR 746.0K
  • Earning Date
  • ADMA 05-07-2025
  • LOAR 05-13-2025
  • Dividend Yield
  • ADMA N/A
  • LOAR N/A
  • EPS Growth
  • ADMA N/A
  • LOAR N/A
  • EPS
  • ADMA 0.84
  • LOAR 0.24
  • Revenue
  • ADMA $459,381,000.00
  • LOAR $402,819,000.00
  • Revenue This Year
  • ADMA $18.45
  • LOAR $24.82
  • Revenue Next Year
  • ADMA $26.96
  • LOAR $19.15
  • P/E Ratio
  • ADMA $23.92
  • LOAR $393.83
  • Revenue Growth
  • ADMA 62.23
  • LOAR 26.88
  • 52 Week Low
  • ADMA $6.84
  • LOAR $45.13
  • 52 Week High
  • ADMA $25.67
  • LOAR $99.16
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 43.06
  • LOAR N/A
  • Support Level
  • ADMA $18.75
  • LOAR N/A
  • Resistance Level
  • ADMA $23.98
  • LOAR N/A
  • Average True Range (ATR)
  • ADMA 1.38
  • LOAR 0.00
  • MACD
  • ADMA -0.34
  • LOAR 0.00
  • Stochastic Oscillator
  • ADMA 17.77
  • LOAR 0.00

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About LOAR LOAR HOLDINGS INC

Loar Holdings Inc in the design, manufacture, and sale of niche aerospace and defense components that are essential for today's aircraft and aerospace and defense systems. Its manufactured products includes auto throttles, lap-belt airbags, two- and three-point seat belts, water purification systems, fire barriers, polyimide washers and bushings, latches, hold-open and tie rods, temperature and fluid sensors and switches, carbon and metallic brake discs, fluid and pneumatic-based ice protection, RAM air components, sealing solutions and motion and actuation devices, among others. It operate across ten manufacturing facilities located in the United States, one manufacturing facility in Germany and one manufacturing facility in the United Kingdom (UK).

Share on Social Networks: